Literature DB >> 17626078

ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.

Wen-hai Feng1, Richard J Kraus, Sarah J Dickerson, Hui Jun Lim, Richard J Jones, Xianming Yu, Janet E Mertz, Shannon C Kenney.   

Abstract

The induction of lytic infection has been proposed as a therapeutic strategy for treating Epstein-Barr virus (EBV)-positive malignancies. To succeed, efficient methods are needed for activating the EBV immediate-early (IE) promoters, Zp and Rp. Here we compared factors which regulate Zp and Rp in AGS gastric carcinoma cells that support a remarkably high level of persistently lytic EBV infection with HeLa cervical cells that permit only tightly latent infection. We found that the level of Zp activity assayed by transient transfection assays with reporter plasmids was high in AGS cells but low in HeLa cells. The level of Rp activity was low in both cell types. Mutational analysis indicated that sequences within Zp located between -70 and +27 relative to the transcription initiation site were sufficient to confer a high level of Zp activity in AGS cells. The Zp CRE motif was necessary for this constitutive activity, while the ZIA and ZIB MEF2D motifs were not. Consistent with these findings, immunoblot analysis indicated that phosphorylated c-Jun, which activates Zp through the CRE motif, was expressed at a much higher level in EBV-infected AGS cells than in EBV-infected HeLa cells. In contrast, ZEB1, which represses Zp via the ZV motif located near the transcription initiation site, was abundant in HeLa cells, while it was absent from AGS cells. Exogenous addition of ZEB1 led to the repression of Zp in AGS cells. We conclude that the unusually high Zp activity level in AGS cells is due to the high abundance of positively acting transcription factors such as c-Jun combined with the low abundance of negatively acting factors such as ZEB1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626078      PMCID: PMC2045427          DOI: 10.1128/JVI.00692-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Independent repressor domains in ZEB regulate muscle and T-cell differentiation.

Authors:  A A Postigo; D C Dean
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells.

Authors:  P MacCallum; L Karimi; L J Nicholson
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

3.  Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Authors:  Jian Huang; Gangling Liao; Honglin Chen; Frederick Y Wu; Lindsey Hutt-Fletcher; Gary S Hayward; S Diane Hayward
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.

Authors:  Gregory K Hong; Margaret L Gulley; Wen-Hai Feng; Henri-Jacques Delecluse; Elizabeth Holley-Guthrie; Shannon C Kenney
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Epstein-Barr virus lytic infection induces retinoic acid-responsive genes through induction of a retinol-metabolizing enzyme, DHRS9.

Authors:  Richard J Jones; Sarah Dickerson; Prassana M Bhende; Henri-Jacque Delecluse; Shannon C Kenney
Journal:  J Biol Chem       Date:  2007-01-22       Impact factor: 5.157

6.  Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Authors:  E M Westphal; A Mauser; J Swenson; M G Davis; C L Talarico; S C Kenney
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

7.  Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression.

Authors:  Wen-Hai Feng; Shannon C Kenney
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.

Authors:  Suzanne Stewart; Christopher W Dawson; Kenzo Takada; John Curnow; Cary A Moody; John W Sixbey; Lawrence S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

9.  NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

Authors:  H L Chua; P Bhat-Nakshatri; S E Clare; A Morimiya; S Badve; H Nakshatri
Journal:  Oncogene       Date:  2006-07-24       Impact factor: 9.867

10.  Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.

Authors:  Serge Grégoire; Xiang-Jiao Yang
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more
  34 in total

1.  Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429.

Authors:  Zhen Lin; Xia Wang; Claire Fewell; Jennifer Cameron; Qinyan Yin; Erik K Flemington
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

2.  Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.

Authors:  Amy L Ellis; Zhenxun Wang; Xianming Yu; Janet E Mertz
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

3.  Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Authors:  Aron R Marquitz; Anuja Mathur; Kathy H Y Shair; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

4.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.

Authors:  Xianming Yu; Patrick J McCarthy; Zhenxun Wang; Daniel A Gorlen; Janet E Mertz
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 7.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

8.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

9.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.

Authors:  Derek Daigle; Lyn Gradoville; David Tuck; Vince Schulz; Ruth Wang'ondu; Jianjiang Ye; Kelly Gorres; George Miller
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.